ClinConnect ClinConnect Logo
Search / Trial NCT06921967

Investigation of the Effect on Ocular Health and Visual Quality With Corneal and Scleral RGP Lenses in Patients With Keratoconus

Launched by UNIVERSITY OF AARHUS · Apr 3, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Contact Lenses Scleral Lenses Corneal Lenses Rigid Gas Permeable Lenses Rigid Lenses Gp Lenses Rgp Lenses Visual Acuity Contrast Sensitivity Higher Order Aberrations Dry Eye Disease Irregular Astimatism Keratoconus

ClinConnect Summary

This clinical trial is exploring how two types of special contact lenses—corneal rigid gas permeable lenses (CRGPL) and scleral rigid gas permeable lenses (SRGPL)—affect eye health and vision quality in people with keratoconus, a condition that causes the cornea to become thin and irregularly shaped. The researchers want to see which type of lens provides better vision improvement, comfort, and overall eye health. They will collect information from participants about their experiences wearing each type of lens and measure various eye health indicators.

To participate in this study, you need to be between 18 to 40 years old and have a diagnosed case of keratoconus with certain vision requirements. Participants will have the opportunity to try both types of lenses during the study, so they can compare their experiences. This trial is important because it will help to better understand how these lenses work for people with keratoconus, especially as the scleral lenses are becoming more popular. If you meet the criteria and are interested in improving your vision, this could be a valuable opportunity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Keratoconus, best spectacle corrected visual acuity \>0.00 log of minimum angle of resolution (logMAR) and age between 18 to 40
  • Exclusion Criteria:
  • K-max \>60D, RGP lens wear at baseline and ocular surface disease, verified through examination of the ocular surface and patient history

About University Of Aarhus

The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported